Status:
COMPLETED
Evaluating the Effectiveness of Tion-Emo Therapy and Technique (TET)
Lead Sponsor:
Rafael Navia
Conditions:
Depressive and Anxiety Disorders
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to explore the new therapy Cion-Emo therapy (TET) and to see if this technique is effective for treating depression and anxiety. Does TET lower anxiety and depressio...
Detailed Description
The TION-EMO theory (TET) was developed in Finland approximately four decades ago with positive results in the public and private sectors. Positive results were also seen in Ecuador. The psychological...
Eligibility Criteria
Inclusion
- Inclusion: Confirmed diagnosis of depressive disorder or anxiety disorder: Based on clinical interview according to DSM criteria
- Age between 18 and 75 years
- Baseline symptom severity
- BAI score ≥ 22 (indicating at least moderate anxiety)
- Ability to attend intervention sessions for 12 weeks as part of the study protocol
- Informed consent signed before enrollment
- Exclusion Criteria: Diagnosis of bipolar disorder, schizophrenia, or psychotic disorders, as these conditions may require different treatment approaches and could confound results.
- Substance abuse or dependency, evaluated in the screaning interview.
- Severe neurological impairment or cognitive disorder, that may limit participation and affect the study outcomes.
Exclusion
Key Trial Info
Start Date :
September 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 8 2025
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT06950970
Start Date
September 14 2023
End Date
February 8 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TET institute for development of psychotherapy and artificial emotion
Portoviejo, Manabí, Ecuador, 130102